drugset / Trial / NCT02171442
Metabolism and Pharmacokinetics of [14C]-BIBR 953 ZW After Administration of Single Doses of [14C]-BIBR 953 ZW Intravenously or [14C]-BIBR 1048 Oral Solution in Healthy Male Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study were to investigate the metabolism and pharmacokinetics of BIBR 1048 MS and BIBR 953 ZW in man.
Timeline
- Start
- 2002-04
- Primary completion
- 2002-05
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabigatran | Unknown | 2.8 mbq | Intravenous |
| Subject | Dabigatran | Unknown | 5 mg | Intravenous |
| Comparator | Dabigatran etexilate | Unknown | 2.8 mbq | Oral |
| Comparator | Dabigatran etexilate | Unknown | 200 mg | Oral |
Indications
No indication recorded.